JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 83 filers reported holding JOUNCE THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 1.59 and the average weighting 0.8%.
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP II, LLC | 10,230,349 | $228,648,000 | 42.85% |
Pharmstandard International S.A. | 662,063 | $14,797,000 | 37.17% |
TRV GP III, LLC | 3,048,780 | $68,140,000 | 24.53% |
Omega Fund Management, LLC | 529,965 | $11,845,000 | 11.64% |
Casdin Capital, LLC | 635,000 | $14,192,000 | 2.50% |
Virtus ETF Advisers LLC | 58,867 | $1,316,000 | 1.14% |
Redmile Group, LLC | 1,182,393 | $26,426,000 | 1.02% |
PFM Health Sciences, LP | 1,923,651 | $42,994,000 | 0.87% |
Elephas Investment Management Ltd | 154,400 | $3,451,000 | 0.63% |
Ghost Tree Capital, LLC | 125,092 | $2,796,000 | 0.57% |